EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Antimicrobial prescribing and guideline adherence in febrile inpatients in the Masanga Fever Study (MaFeStu) in Sierra Leone: a substudy within a prospective observational study

Laura C Kalkman, Emmanuel M Kanu, Emmanuel B Bache, Jenneh Foray, Haja Sarrah Sherriff, Ika Septihandayani, Emil Kelling, Yusufu M Tarawally, Kadiatu Sesay, Emmanuel Nyallay, Tom Theiler, Viktoria Rudolf und 19 weitere

The Lancet Microbe · 2026-11 · 101552

DOI: 10.1016/j.lanmic.2026.101552 ↗

Kurz gefasst

Leitlinie in der Zeitschrift The Lancet Microbe, 2026-11. Verfasst von Laura C Kalkman und 30 weiteren Autor:innen. Beteiligte Einrichtung: Masanga Medical Research Unit (MMRU) and Masanga Hospital, Masanga, Sierra Leone; Centre of Tropical Medicine and Travel Medicine, Department of Infe…. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Association for International Cooperation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antimicrobial resistance is increasing in sub-Saharan Africa, yet detailed data on prescribing practices remain scarce. We aimed to characterise antimicrobial compounds prescribed at admission, assess their concordance with treatment guidelines, and examine antimicrobial compounds prescribed during hospitalisation.

Methods

We conducted a substudy of the Masanga Fever Study (MaFeStu), a prospective observational study of febrile inpatients at Masanga Teaching Hospital in rural Sierra Leone from Sept 26, 2023, to Sept 26, 2024. Patients aged 5 months or older who were assessed within 3 h of admission and had documented fever (tympanic temperature >37·5°C) or reported fever within the previous 72 h were eligible. Patients were excluded if study procedures would delay urgent care, and those without available medication records were excluded post hoc. Clinical data and diagnoses were recorded prospectively, and antimicrobial prescriptions were extracted from patient files after discharge. The primary outcome was concordance of antimicrobial compounds initiated at admission with the hospital protocol and WHO guidance, assessed using predefined decision rules. Prescribed compounds were also classified by WHO Access, Watch, and Reserve category and indication. Secondary analyses summarised antimicrobial compounds prescribed during hospitalisation, including oral step-down and culture-directed therapy.

Findings

689 febrile inpatients included in the analysis, the median age was 14 years (IQR 1·8–34·0), 358 (52%) were female, and race and ethnicity data were not collected. At admission, 487 (71%; 95% CI 67–74) patients received one or more antimicrobial compounds. Of 882 antimicrobial compounds prescribed, 573 (65%; 95% CI 62–68) were WHO Access antibiotics, and 309 (35%; 95% CI 32–38) were WHO Watch antibiotics. Ceftriaxone was the most frequently prescribed compound (268 [30%] of 882). Lower respiratory tract infections, sepsis, and skin and soft tissue infections accounted for the largest share of compounds prescribed, overall and within the Watch category. Overall, 650 (74%; 95% CI 71–77) of 882 prescribed compounds were concordant with the hospital protocol, compared with 491 (56%; 95% CI 52–59) under WHO guidance. Discordant prescribing under both guidelines was concentrated in common indications, particularly sepsis and lower respiratory tract infection. During hospitalisation, 58 (4·9%; 95% CI 3·8–6·3) of 1183 antimicrobial compounds prescribed represented oral step-down therapy, and 73 (6·2%; 95% CI 4·9–7·7) were culture-directed.

Interpretation

Most prescribed compounds were WHO Access antibiotics and were largely concordant with hospital guidance and, to a lesser extent, with WHO guidance. Prescribing patterns suggest that strengthening diagnostics, refining treatment guidelines, and improving guideline familiarity could enhance guideline-concordant prescribing and antimicrobial stewardship in similar settings with constrained diagnostic and stewardship resources. Funding Centre of Tropical Medicine and Travel Medicine, Amsterdam UMC, University of Amsterdam; Deutsche Gesellschaft für Internationale Zusammenarbeit/Klinikpartnerschaften.

Autor:innen und Institutionen

  • Masanga Medical Research Unit (MMRU) and Masanga Hospital, Masanga, Sierra Leone; Centre of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centres, University of A…
  • Masanga Medical Research Unit (MMRU) and Masanga Hospital, Masanga, Sierra Leone.
  • Masanga Medical Research Unit (MMRU) and Masanga Hospital, Masanga, Sierra Leone; Institute of Medical Microbiology, University of Münster, Münster, Germany.
  • Department of Infection, Barts Health NHS Trust, Royal London Hospital, London, UK.
  • Department of Surgery, Connaught Hospital, University of Sierra Leone Teaching Hospitals Complex, Ministry of Health, Freetown, Sierra Leone.
  • Infection and Immunity Clinical Academic Group, Institute for Infection and Immunity, St George's University Hospitals NHS Foundation Trust, St George's University of London, London, UK; Institut für Tropenmedizin and G…

Förderung

  • German Association for International Cooperation

Zitieren

APA

Kalkman, L. C., Kanu, E. M., Bache, E. B., Foray, J., Sherriff, H. S., Septihandayani, I., Kelling, E., Tarawally, Y. M., Sesay, K., Nyallay, E., Theiler, T., Rudolf, V., Lamb, G., Kamara, I. F., Sesay, M. O., Kargbo, I. M., Sesay, M. D., Kargbo, T. Y., Kamara, A. F., …, & MaFeStu consortium (2026). Antimicrobial prescribing and guideline adherence in febrile inpatients in the Masanga Fever Study (MaFeStu) in Sierra Leone: a substudy within a prospective observational study. The Lancet Microbe, 101552. https://doi.org/10.1016/j.lanmic.2026.101552

Vancouver

Kalkman LC, Kanu EM, Bache EB, Foray J, Sherriff HS, Septihandayani I, et al. Antimicrobial prescribing and guideline adherence in febrile inpatients in the Masanga Fever Study (MaFeStu) in Sierra Leone: a substudy within a prospective observational study. The Lancet Microbe. 2026:101552. doi:10.1016/j.lanmic.2026.101552

BibTeX
@article{Kalkman2026,
  author = {Kalkman, Laura C and Kanu, Emmanuel M and Bache, Emmanuel B and Foray, Jenneh and Sherriff, Haja Sarrah and Septihandayani, Ika and Kelling, Emil and Tarawally, Yusufu M and Sesay, Kadiatu and Nyallay, Emmanuel and Theiler, Tom and Rudolf, Viktoria and Lamb, Georgia and Kamara, Ibrahim F and Sesay, Mohamed O and Kargbo, Islam M and Sesay, Mohamed D and Kargbo, Thomas Y and Kamara, Alie F and Jawara, Hassan and Bull, Matthew A and Bangura, James and Bangura, Alie and Kabba, Mustapha S and Krishna, Sanjeev and Carrara, Elena and Hermans, Sabine M and Hanscheid, Thomas and Schaumburg, Frieder and Grobusch, Martin P and MaFeStu consortium, MaFeStu consortium},
  title = {Antimicrobial prescribing and guideline adherence in febrile inpatients in the Masanga Fever Study (MaFeStu) in Sierra Leone: a substudy within a prospective observational study},
  journal = {The Lancet Microbe},
  year = {2026},
  pages = {101552},
  doi = {10.1016/j.lanmic.2026.101552}
}
Kostenlos starten →